Trexquant Investment’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,239	Closed	-$879K	–	2092
2025 Q4	$879K	Buy	+28,239	New	+$775K	0.01%	1220
2025 Q1	–	Sell	-120,065	Closed	-$2.3M	–	1900
2024 Q4	$2.3M	Sell	120,065 -22,576	-16%	-$491K	0.03%	810
2024 Q3	$3.25M	Buy	142,641 +100,817	+241%	+$1.65M	0.04%	640
2024 Q2	$544K	Buy	+41,824	New	+$579K	0.01%	1217
2023 Q1	–	Sell	-35,887	Closed	-$1.05M	–	1806
2022 Q4	$1.05M	Buy	+35,887	New	+$827K	0.03%	624
2018 Q4	–	Sell	-669	Closed	-$56K	–	1328
2018 Q3	$56K	Buy	+669	New	+$63.1K	﹤0.01%	909
2018 Q2	–	Sell	-1,050	Closed	-$110K	–	1251
2018 Q1	$110K	Sell	1,050 -13	-1%	-$1.41K	0.01%	1012
2017 Q4	$166K	Buy	+1,063	New	+$135K	0.02%	970